Skip to content

Effets of Qishen Yiqi Dripping pill on serum resistin and related factors in patients with stable angina pectoris of coronary artery disease: single blind, placebo and randomized controlled trial

Effets of Qishen Yiqi Dripping pill on serum resistin and related factors in patients with stable angina pectoris of coronary artery disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013595
Enrollment
Unknown
Registered
2017-11-29
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable angina

Interventions

Western conventional treatment + Qishenyiqi drop pills:Aspirin, rosuvastatin calcium tablets, metoprolol sustained-release tablets, isosorbide mononitrate tablets, qishen yiqi drop pills
Western conventional treatment + placebo: Aspirin, rosuvastatin calcium tablets, metoprolol sustained-release tablets, isosorbide mononitrate tablets,placebo

Sponsors

Weifang City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) in line with the diagnosis of coronary heart disease with stable angina; 2) in line with TCM diagnosis of Qi deficiency blood stasis; 3) aged 40-70 years; 4) signed informed consent.

Exclusion criteria

Exclusion criteria: 1) diagnosis of patients with acute coronary syndromes; 2) patients who had aortic dissection, acute pulmonary embolism; patients with malignant arrhythmia, acute heart failure, cardiogenic shock; 3) Hyperactivity and hyperactivity; 4) patients with grade I and IV severity of stable angina pectoris; 5) patients undergoing thrombolysis or percutaneous coronary intervention; 6) patients with severe liver or kidney dysfunction or malignancy of patients.

Design outcomes

Primary

MeasureTime frame
resistin;adiponectin(APN);C reactive protein(CRP);Ankle brachial index(ABI);

Countries

China

Contacts

Public ContactGuohua Chen

Weifang City People's Hospital

jkgl2186@163.com+86 13305365555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026